Claypath and University Medical Group
Health and care · Healthcare site
First report 7 Mar 2022•Latest report 7 Mar 2022
Reports, concerns and published responses
Reports over time
Reports naming this recipient by issue year.
* 2026 is projected from reports observed to 7 Sep 2026.
- Reports
- 1
- Published responses
- 100%
- Concerns addressed
- 1
- Stated actions
- 4
Naming this recipient
Found for named reports
Across all linked responses
Described in responses
Concerns and recipient responses
Statements from Claypath and University Medical Group linked to the concerns in each report. Select any concern, action or position to view the source wording.
-
Concerns raised1
Failure of nitrofurantoin prescribing guidance to provide advice on monitoring for sudden pulmonary deterioration during short-term treatment in elderly patients
Actions described in response An action is something this recipient says it has done, is doing, or plans to do in response to the concern raised.2
-
Action
Alert prescribing clinicians to nitrofurantoin’s serious breathlessness side effects and the need for prompt patient reporting.
-
Action
Write to the Local Medicine Management Team highlighting nitrofurantoin’s life-threatening side effect.
Information checked against published PFD reports and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations
Data last updated 7 September 2026